Rothbaum Wayne P.

Rothbaum Wayne P. serves as a Director at Iovance Biotherapeutics, Inc., a company focused on innovative cell therapy solutions in the healthcare sector. His recent trading activity includes significant purchase activity, with a total investment of approximately $45.8 million reported from February 20, 2024, to March 5, 2024. The largest disclosed move was a purchase of $45.75 million in Iovance Biotherapeutics, indicating a strong commitment to the company's future.